RNA Processing and Alternative Splicing: Mechanisms, Regulation, and Pathology
Core Principles of the Central Dogma and Molecular Terminology
- The Central Dogma of Molecular Biology:
- Information flow in living biological systems follows a unidirectional pathway: .
- Transcription converts genetic information contained within the deoxyribonucleotide sequence of double-stranded DNA into a ribonucleotide sequence of RNA.
- Translation converts the ribonucleotide sequence of messenger RNA (mRNA) into a defined linear sequence of amino acids in a polypeptide chain.

Linguistic and Mechanistic Definitions:
- Transcribe: To make an exact written or complementary copy of a text or document within the same chemical language. In molecular biology, this corresponds to synthesizing RNA from DNA where both polymers consist of nucleic acid bases.
- Translate: To convert from one distinct language into another, or to alter state and form. In molecular biology, this refers to changing chemical languages from nucleotide triplets (codons) in nucleic acids into amino acid residues in proteins.
Biochemical Distinctions Between DNA and RNA:
- Pentose Sugar Backbone: RNA contains ribose, which possesses a hydroxyl group () at the carbon position. DNA contains , which bears a hydrogen atom () at the carbon position.
- Nitrogenous Base Composition: RNA utilizes uracil (), which has a hydrogen atom () at the carbon-5 position of the pyrimidine ring. DNA utilizes thymine (), which features a methyl group () at the carbon-5 position.
- Chemical Reactivity: The presence of the reactive group on ribose makes RNA more chemically labile and prone to hydrolysis, but also enables unique tertiary folding and enzymatic mechanisms such as the formation of branched RNA structures during splicing.

- Polypeptide Composition and Structure:
- Proteins are linear biopolymers assembled from 20 distinct amino acid monomers linked together by covalent peptide bonds.
- Each peptide bond is formed through a condensation reaction joining the group of one amino acid to the group of the next, releasing a water molecule.
- A representative heptapeptide chain displays structural polarity running from the protonated amino terminus () to the ionized carboxyl terminus ():
- Serine (Ser1): Polar uncharged side chain ().
- Histidine (His2): Basic imidazole side chain capable of protonation.
- Cysteine (Cys3): Thiol/sulfhydryl side chain () involved in disulfide bridge formation.
- Methionine (Met4): Nonpolar thioether side chain ().
- Glutamic acid (Glu5): Negatively charged carboxylate side chain ().
- Leucine (Leu6): Branched hydrophobic hydrocarbon side chain ().
- Lysine (Lys7): Positively charged primary amine side chain ().

Eukaryotic Gene Organization and Vocabulary
- Gene Anatomy and Functional Sequences:
- Promoter: A specific non-coding DNA sequence positioned upstream of a gene where RNA polymerase binds to initiate transcription.
- Regulatory Sequences: Enhancer and silencer sequences that serve as binding platforms for sequence-specific transcription factors, thereby modulating the recruitment and transcriptional rate of RNA polymerase.
- TATA Box: An AT-rich consensus core promoter motif located approximately upstream () of the transcription start site. It is recognized directly by the TATA-binding protein (TBP), which nucleates the assembly of the pre-initiation complex.
- Transcription Start Site (TSS): The precise DNA nucleotide coordinate designated as where RNA synthesis physically commences.
- Transcribed Region: The full span of DNA between the TSS and the termination region that is copied into pre-mRNA.
- Primary () Transcript (Pre-mRNA): The initial, full-length, unmodified single-stranded RNA molecule generated directly by RNA polymerase II. It represents a direct colinear copy of the transcribed region.
- Introns: Intervening non-coding segments within the primary transcript that are excised during nuclear RNA processing.
- Exons: Expressed regions retained within the mature transcript that are spliced together to form the continuous mRNA sequence.
- Coding Sequence (CDS): The continuous series of nucleotide triplets that directly dictates the amino acid sequence of the protein during translation.
- Untranslated Regions (UTRs): Segments of mature mRNA that do not encode amino acids:
- : Located between the cap and the translation start codon (
AUG). Functions in mRNA stability and ribosome recruitment. - : Located between the translation stop codon (
UAA,UAG, orUGA) and the poly-A tail. Regulates mRNA stability, subcellular localization, and translation efficiency. - Open Reading Frame (ORF): An uninterrupted stretch of codons beginning with an initiation codon (
AUG) and continuing in-frame until a termination codon is encountered. - Transcription Termination Sequences:
- In prokaryotes: An intrinsic palindromic sequence that transcribes into a self-complementary GC-rich hairpin stem-loop followed by a poly-U tract, which physically destabilizes and dislodges RNA polymerase.
- In eukaryotes: Governed by polyadenylation signal sequences recognized by specialized protein complexes while RNA polymerase II continues transcribing downstream.
RNA Polymerase II Termination and Polyadenylation
- Overview of Primary Transcript Modifications:
- Pre-mRNA undergoes three major co-transcriptional processing events:
- Addition of a 7-methylguanosine cap () to the end via an unusual triphosphate linkage.
- Cleavage of the end and template-independent addition of a polyadenine (poly-A) tail.
- Splicing to remove non-coding introns and join exons.

- Mechanism of Eukaryotic Transcription Termination:
- RNA Polymerase II transcribes across the genomic polyadenylation signal (
AATAAAin DNA, producingAAUAAAin nascent pre-mRNA). - Downstream of the polyadenylation signal lies a cleavage site (frequently characterized by a
CAdinucleotide), followed by a downstream element rich in guanine and thymine/uracil residues (G-T rich in gDNA, G-U rich in pre-mRNA). - Assembly of Cleavage and Termination Factors:
- CPSF (Cleavage and Polyadenylation Specificity Factor): Directly binds the upstream
AAUAAApoly(A) signal motif. - CStF (Cleavage Stimulatory Factor): Binds to the downstream G-U or U-rich sequence element.
- CFI and CFII (Cleavage Factors I and II): Form a multiprotein bridging complex with CPSF and CStF, looping the intervening RNA.
- The cleavage factors stimulate endonucleolytic cleavage at the designated poly(A) site (
CAjunction), releasing the elongating RNA Polymerase II from the DNA template. - The free generated at the cleavage site of the primary transcript is recognized by poly-A polymerase (PAP), which adds a non-templated homopolymeric tail of approximately adenine residues (Poly-A tail).
- RNA Polymerase II transcribes across the genomic polyadenylation signal (


- Functional Roles of the Poly-A Tail:
- Facilitates the coordinated export of mature mRNA from the nucleus to the cytoplasm through the nuclear pore complex.
- Protects the mRNA from rapid exonucleolytic degradation by cytoplasmic nucleases.
- Collaborates with the and translation initiation factors (e.g., eIF4G/PABP interactions) to circularize mRNA, promoting efficient translational recycling by ribosomes.
Nuclear mRNA Export, Surveillance, and Viral Mimicry
- Nuclear mRNP Assembly and Export Pathway:
- Transcription elongation and RNA processing occur alongside the assembly of a ribonucleoprotein particle (mRNP).
- The TREX complex (Transcript Export Complex) associates with the nascent transcript during RNA polymerase II elongation.
- Upon completion of RNA processing, a defined set of RNA-binding proteins (RBPs) assemble onto the mRNA:
- Cap-Binding Complex (CBC): Anchors to the cap.
- Npl3, Yra1, and Sub2: Facilitate mRNP maturation and recruitment of export factors.
- Nab2: Binds tightly to the poly-A tail.
- Mex67-Mtr2 Heterodimer: Acts as the dedicated mRNA exporter, docking the mature mRNP to the Nuclear Pore Complex (NPC).
- Regulated ubiquitination and release of Sub2 and Yra1 prime the mRNP for NPC translocation.
- Directional Translocation and Cytoplasmic Remodeling:
- The mRNP translocates through the central channel of the NPC.
- At the cytoplasmic face of the NPC, the DEAD-box RNA helicase Dbp5, activated by Gle1 and the cofactor inositol hexakisphosphate (), hydrolyzes ATP to strip Mex67, Mtr2, Nab2, and Npl3 from the mRNA.
- Stripping prevents backward slippage of the transcript into the nucleus, conferring strict directionality to export.
- The displaced nuclear RBPs are recycled back into the nucleoplasm.

Nuclear and Cytoplasmic RNA Surveillance Systems:
- Nuclear Quality Control: Pre-mRNAs that fail proper processing (such as transcripts lacking a poly-A tail or failing to recruit export factors) are retained inside the nucleus. Nuclear retention leads to targeting and degradation by the Exosome, a multi-subunit ribonuclease complex.
- Cytoplasmic Quality Control: If an aberrantly unprocessed RNA lacking a poly-A tail escapes into the cytoplasm, cytoplasmic ribonuclease complexes recognize it as abnormal or foreign and degrade it.
Viral Structural Mimicry: The SARS-CoV-2 Paradigm:
- SARS-CoV-2 possesses a positive-sense single-stranded RNA () genome of approximately .
- To evade host cytoplasmic surveillance and exploit host translation machinery, the viral genomic RNA contains a eukaryotic-like and a .
- Infection and Replication Dynamics:
- Viral spike () protein engages human host receptor ACE2, followed by proteolytic priming by host protease TMPRSS2 or endosomal cathepsins to mediate viral entry.
- Upon uncoating, primary translation of the viral genomic RNA yields polyproteins 1a and 1b (ORF1a/ORF1b), which are cleaved by viral proteases into individual non-structural proteins (nsps).
- Replicative nsps assemble the Replicase Complex on endoplasmic reticulum (ER)-derived double-membrane vesicles (DMVs).
- Viral RNA synthesis yields subgenomic mRNAs (sg mRNAs) that encode structural proteins (Spike [], Membrane [], Nucleocapsid [], and Envelope []) and accessory proteins.
- Every sg mRNA is capped and polyadenylated, allowing efficient translation while shielding the viral transcripts from cellular nucleases that degrade foreign unpolyadenylated RNA.
- Virions assemble in the ER-Golgi intermediate compartment (ERGIC) and exit the host cell via exocytosis.

The Biochemical Mechanism of Pre-mRNA Splicing
Conserved Splice Site Sequences:
- Pre-mRNA splicing depends on three conserved sequence elements within each intron:
- : Located at the exon-intron boundary with the consensus
AG | GUAAGU(invariant dinucleotideGUat the start of the intron). - Branch Site: Located upstream of the with the consensus
CUGACU, containing an invariant, non-paired Adenine (A) residue. - : Located at the intron-exon boundary with the consensus
UCUCUCACAG | G(polypyrimidine tract followed by invariant dinucleotideAG).
The Spliceosome Machinery:
- Splicing is executed by the spliceosome, a dynamic macromolecular ribonucleoprotein complex consisting of five small nuclear ribonucleoproteins (snRNPs: U1, U2, U4, U5, and U6) along with numerous non-snRNP protein factors.
- Sequential Assembly Steps:
- Step A: U1 snRNP base-pairs with the conserved . Simultaneously, U2 snRNP pairs with the branch site consensus sequence, bulging out the critical invariant Adenine.
- Step B: The pre-assembled U4/U6U5 tri-snRNP complex is recruited. U5 binds sequences in both the donor and acceptor exons.
- Step C: Major conformational rearrangements occur: U1 and U4 snRNPs dissociate, activating the catalytic center composed of U6 and U2 snRNAs coordinated with catalytic magnesium ions.
- Step D: Catalytic cleavage and ligation reactions occur, releasing the intron as a lariat and joining the exons.

- The Two-Step Transesterification Mechanism:
- Splicing proceeds through two sequential bimolecular nucleophilic transesterification reactions, conserving the total number of phosphodiester bonds without requiring ATP hydrolysis for the bond rearrangements:
- First Transesterification Reaction (Lariat Formation):
- The free nucleophilic group of the invariant branch site Adenine executes an attack on the phosphodiester bond at the (the boundary between Exon 1 and the invariant
GUof the intron). - Cleavage of the exon-intron phosphodiester bond yields a free on Exon 1.
- Simultaneously, the phosphoryl group of the intron's terminal guanine is covalently linked to the of the branch site Adenine.
- This generates a branched, circular-looped structure termed an intron lariat, characterized by an unusual .
- Note that this branch site Adenine simultaneously maintains standard with its flanking neighbors in the pre-mRNA chain, making it a triply connected nucleotide.
- The free nucleophilic group of the invariant branch site Adenine executes an attack on the phosphodiester bond at the (the boundary between Exon 1 and the invariant
- Second Transesterification Reaction (Exon Ligation):
- The newly liberated of Exon 1 acts as a nucleophile, attacking the phosphodiester bond at the (between the invariant
AGof the intron and the first base of Exon 2). - This ligates Exon 1 to Exon 2 through a standard .
- The excised intron is released in lariat form and subsequently linearized by a nuclear debranching enzyme before rapid degradation.
- The newly liberated of Exon 1 acts as a nucleophile, attacking the phosphodiester bond at the (between the invariant

- Chemical Incompatibility of Deoxyribonucleotides:
- If the branch site Adenine ribonucleotide is substituted by a deoxyadenosine (), splicing is completely abolished.
- Deoxyribose has only a hydrogen atom () at its carbon; lacking the nucleophilic , it cannot launch the initial transesterification attack on the .

Alternative Splicing Mechanisms and Regulatory Rules
Foundations of Alternative RNA Processing:
- Alternative splicing enables a single pre-mRNA transcript to generate multiple distinct mature mRNA isoforms by including or excluding specific exons.
- This mechanism dramatically expands proteomic diversity from a limited number of genes.
- Splicing decisions are governed by the binding of regulatory RNA-binding proteins (RBPs) (such as SR proteins or hnRNPs) that bind splice sites or adjacent splicing enhancers/silencers, physically blocking or facilitating spliceosome recruitment.
Mechanistic Splicing Rules:
- Rule 1 (Blocking the Donor Site or Branch Site):
- If an RBP binds and sterically masks the or the branch site, the first transesterification reaction cannot occur.
- Intron removal is blocked, resulting in intron retention.
- Rule 2 (Blocking the Acceptor Site):
- If an RBP binds and sterically shields the of an intron, the spliceosome cannot recognize the exon immediately downstream.
- Instead of terminating splicing, the spliceosome scans downstream ( toward the transcript end) to identify the next accessible .
- The intervening exon is skipped entirely and excised along with the flanking introns as a single giant lariat, resulting in exon skipping.
Alternative Splicing in a Five-Exon Model Gene:
- Consider a transcript containing Exons 1 through 5, separated by Introns 1, 2, 3, and 4:
- Constitutive Splicing (Protein A): All introns are excised; exons join sequentially to yield an mRNA containing Exons 1-2-3-4-5.
- Blocking the Acceptor Site of Intron 2 (Protein B): Splicing skips Exon 3; Exon 2 is joined directly to Exon 4, producing an mRNA containing Exons 1-2-4-5.
- Blocking the Acceptor Site of Intron 3 (Protein C): Splicing skips Exon 4; Exon 3 is joined directly to Exon 5, producing an mRNA containing Exons 1-2-3-5.
Case Studies in Alternative Splicing and Disease
- Case Study 1: Splicing Switch in the Cyclin-Dependent Kinase Inhibitor (CDKI) Gene:
- Genetic Architecture:
- The CDKI gene consists of three exons (Exon 1, Exon 2, Exon 3).
- An initiation start codon (
ATG) is located in Exon 1. - Exon 2 contains a premature stop codon (
TAA). - Exon 3 contains the legitimate termination stop codon (
TAG). - State A: CDKI RNA-Binding Protein Absent:
- In the absence of the specific CDKI RBP, constitutive splicing occurs across all three exons.
- The mature mRNA contains Exons 1, 2, and 3 (a larger mRNA transcript).
- When translated, the ribosome initiates at
ATGin Exon 1 but encounters the premature stop codon (TAA) in Exon 2. - Translation terminates prematurely, yielding a small, truncated, non-functional CDKI protein.
- State B: CDKI RNA-Binding Protein Present:
- The CDKI RBP binds directly to the of Intron 1.
- This block forces the spliceosome to skip Exon 2 and splice Exon 1 directly to the acceptor site of Exon 3.
- The mature mRNA contains only Exons 1 and 3 (a smaller mRNA transcript).
- Because Exon 2 is excluded, the reading frame extends continuously from Exon 1 across into Exon 3 until reaching the stop codon
TAG. - Translation yields a larger, functional CDKI protein capable of regulating cell cycle progression.

- Diagnostic Gel Electrophoresis Profiling (Northern Blot):
- On an agarose gel separating mRNA by molecular weight, shorter RNA molecules migrate faster (traveling further toward the bottom/anode).
- When CDKI RBP is not expressed, the resulting mRNA contains all three exons and forms a band positioned higher on the gel (slower mobility).
- When CDKI RBP is expressed, the resulting mRNA lacks Exon 2 and forms a band positioned lower on the gel (faster mobility).

- Case Study 2: Voltage-Gated Calcium Channels ( / CACNA1B):
- The CACNA1B gene encodes the pore-forming subunit of the (N-type) voltage-gated calcium channel, which contains 46 exons.
- Alternative splicing fine-tunes channel biophysical properties, pharmacology, and signaling across distinct neuronal populations:
- Cassette Exons (Exons 18a, 24a, 31a):
- Exon 18a inclusion () occurs predominantly in adult tissues and the superior cervical ganglion (SCG), whereas Exon 18a skipping () characterizes embryonic stages and the cerebral cortex.
- Exon 24a inclusion () is enriched in whole brain tissue.
- Exon 31a inclusion () is found in SCG neurons, while being excluded () in broader brain regions.
- Mutually Exclusive Exons (Exons 37a and 37b):
- Splicing selects either Exon 37a or Exon 37b, but never both in the same mature mRNA.
- Exon 37a expression is restricted to specialized pain-sensing peripheral sensory neurons (nociceptors).
- Exon 37b is ubiquitously expressed across all standard central and peripheral neurons (and also in nociceptors).
- The inclusion of Exon 37a alters channel inactivation kinetics and modulates channel responsiveness to G-protein coupled receptor ()-mediated inhibition (e.g., opioid receptor signaling), influencing clinical pain sensitivity.

- Case Study 3: Splicing Dysregulation in Human Cardiovascular Disease:
- In cardiac tissue, multiexon genes encoding sarcomeric structural proteins (e.g., titin [TTN]) and ion channels represent alternative splicing hotspots.
- Splicing misregulation—triggered by genetic mutations in splice sites or dysregulation of cardiac splicing factors (e.g., RBM20, RBM24)—disrupts contractile and electrophysiological functions.
- Aberrant splicing events can cause out-of-frame exon skipping, introducing premature termination codons that trigger Nonsense-Mediated Decay (NMD) and deplete essential cardiac proteins, driving dilated cardiomyopathy and heart failure.
- Therapeutic strategies under development include antisense oligonucleotides (ASOs) and small-molecule splicing modulators designed to block aberrant splice sites or restore normal exon inclusion.
Systematic Mapping of Gene Mutations to Expression Phenotypes
Mutation Position Mapping Across a Model Gene:
- Consider a model eukaryotic gene comprising three exons (Exons 1, 2, 3) and two intervening introns (Introns 1, 2):
- Position A: Core promoter / TATA Box.
- Position B: in Exon 1.
- Position C: Translation Initiation Codon (
ATG) in Exon 1. - Position D: of Intron 1.
- Position E: Protein-coding region within Exon 2.
- Position F: of Intron 2.
- Position G: Branch Site Adenine of Intron 2.
- Position H: Legitimate Translation Stop Codon in Exon 3.
- Position I: Polyadenylation Signal (
AATAAA) in the .
Phenotypic Consequences of Specific Mutations:
- Mutation at Position A (TATA Box): Prevents assembly of the pre-initiation complex and recruitment of RNA Polymerase II. Result: No primary transcript produced, completely abolishing both mRNA and protein expression on gels.
- Mutation at Position C (
ATGStart Codon): The pre-mRNA is transcribed and spliced normally (mRNA size unchanged). However, ribosomes cannot initiate translation at the correct position, leading to failure of protein production or synthesis of aberrant out-of-frame peptides. - Mutation at Position D (Intron 1 Acceptor Site): Destroys the consensus
AGacceptor. The spliceosome cannot join Exon 1 to Exon 2 and scans downstream to the acceptor of Intron 2. Result: Exon 2 is skipped, yielding a shorter mRNA. - Mutation at Position E (Nonsense Mutation): Introduces a premature stop codon into Exon 2. Transcription and splicing proceed normally, leaving mRNA size identical to wild type. However, translation aborts prematurely, producing a truncated (smaller) protein.
- Mutation at Position F (Intron 2 Donor Site): Destroys the consensus
GUdonor. Intron 2 cannot undergo the first transesterification step, resulting in intron retention. The mature mRNA is abnormally long (includes Intron 2 sequence). - Mutation at Position G (Branch Site Adenine): Replacing the branch site Adenine with Cytosine (or another base) prevents formation of the lariat linkage, blocking excision of Intron 2 and causing intron retention.
- Mutation at Position H (Stop Codon): Destroys the normal termination codon. Splicing and mRNA size remain unchanged. The ribosome continues translating past Exon 3 into the until encountering the next fortuitous in-frame stop codon, producing an abnormally large protein.
- Mutation at Position I (Polyadenylation Signal): Prevents endonucleolytic cleavage by CPSF/CStF and tail addition by poly-A polymerase. The transcript lacks a poly-A tail, cannot be exported to the cytoplasm, and is degraded within the nucleus by the exosome.
Questions & Application Problems
Question on Polyadenylation Failure:
- Problem: A mutant gene is transcribed to create a primary () transcript, but RNA processing fails and the poly-A tail is not added. What are the molecular outcomes?
- Evaluation of Outcomes:
- Outcome 1 (Transcript stuck in nucleus): True. The poly-A tail and associated proteins (e.g., Nab2, PABP) are required to assemble an export-competent mRNP; without it, the transcript cannot transit the NPC.
- Outcome 2 (No protein produced): True. Because the transcript fails nuclear export, it never reaches the cytoplasmic ribosomes for translation.
- Outcome 3 (Primary transcript longer than normal): False. The initial primary transcript is transcribed by RNAP II regardless; the length of the uncleaved pre-mRNA is determined by where RNAP II eventually terminates, but failure of polyadenylation specifically leaves the transcript without the terminal poly(A) modification.
- Outcome 4 (Degradation if translocated to cytoplasm): True. Any unpolyadenylated mRNA that escapes into the cytoplasm is targeted and rapidly cleared by cytoplasmic nucleases.
- Outcome 5 (No effect): False. All standard eukaryotic protein-coding mRNAs (with the exception of non-polyadenylated replication-dependent histone mRNAs) require a poly-A tail for stability and function.
Question on Intron Removal Requirements:
- Problem: Which of the following alterations prevent or alter normal intron removal?
- Changing the DNA sequence specifying the branch site from
AtoC. - Replacing the ribo-A at the branch site with a deoxyribo-A.
- Altering the sequence of the donor site (
GU). - Altering the sequence of the acceptor site (
AG).
- Conclusion: All four alterations disrupt normal splicing. The
AtoCmutation and the deoxyribo-A substitution both remove the essential nucleophilic required for the first transesterification reaction. Altering either the donor or acceptor consensus prevents spliceosome recognition and pairing.
Question on Exon Skipping vs. Intron Retention:
- Problem: In a 5-exon gene (Exons 1–5), which intervention specifically generates an mRNA encoding Protein B (which contains Exons 1, 2, 4, and 5)?
- A. Blocking the donor site of Intron 2.
- B. Blocking the acceptor site of Intron 2.
- C. Blocking the donor site of Intron 3.
- D. Blocking the acceptor site of Intron 3.
- Resolution: Option B is correct. Blocking the of Intron 2 prevents the spliceosome from splicing to Exon 3, causing the machinery to skip Exon 3 and splice directly to the acceptor site of Intron 3 (Exon 4). In contrast, blocking donor sites (Options A or C) leads to intron retention rather than clean exon skipping.
Question on CDKI Gel Electrophoresis Analysis:
- Problem: Analysis of CDKI mRNA shows a single high-molecular-weight band in Lane A and a single lower-molecular-weight band in Lane B. Which condition corresponds to each lane?
- Resolution: Lane A represents cells lacking the CDKI RNA-binding protein (where Exon 2 is retained, producing a larger, 3-exon mRNA). Lane B represents cells expressing the CDKI RNA-binding protein (where Exon 2 is skipped, producing a smaller, 2-exon mRNA).
- Impact of Blocking Donor vs. Acceptor: If the CDKI RBP were engineered to block the of Intron 1 instead of the acceptor site, Intron 1 would be retained, making the resulting mRNA even larger than the constitutive 3-exon transcript.